Kathleen Welsh
Dermatology · San Francisco, CANPI 1851459994
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $103,062 of the $148,968 with a category attached, or 69.2%. AbbVie accounts for 88.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $66,717 and has fallen 98.5% since, to $1,012 in 2025. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 265 payments — averaging $562.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$132K
- Merz North America, Inc.$16K
- Galderma Laboratories, L.p.$614
- Pfizer$270
- Solta Medical, A Division Of Bausch Health US, LLC$236
- Almirall LLC$150
- plus $137 from 1 others
What the payments were for
- Consulting fees$24,53316%
- Speaking & faculty fees$103,06269%
- Travel & lodging$8601%
- Food & beverage$17,48012%
- Education$340%
- Gifts$3,0002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 169 | $131,573 |
| Merz North America, Inc. | 65 | $15,989 |
| Galderma Laboratories, L.p. | 17 | $614 |
| Pfizer | 7 | $270 |
| Solta Medical, A Division Of Bausch Health US, LLC | 5 | $236 |
| Almirall LLC | 1 | $150 |
| Revance Therapeutics, Inc. | 1 | $137 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$12,965
- XEOMIN$5,855
- BOTOX$335
- ASCLERA$137
- DAXXIFY$137
How this compares
$148,968 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $47,845 |
| Clobetasol Propionate | 20 | $1,455 |
| Minoxidil | 85 | $1,207 |
| Doxycycline Hyclate | 14 | $777 |
| Fluorouracil | 12 | $748 |
| Imiquimod | 11 | $252 |
| Triamcinolone Acetonide | 25 | $173 |
| Dutasteride | 12 | $155 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Francisco
- Tina BhutaniSan Francisco$1.1M
- Sarina ElmariahSan Francisco$510K
- Timothy BergerSan Francisco$270K
- Marlys FassettSan Francisco$168K
- Caren CampbellSan Francisco$149K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.